Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein - Functional consequences of their interaction

被引:257
作者
Grigorian, M
Andresen, S
Tulchinsky, E
Kriajevska, M
Carlberg, C
Kruse, C
Cohn, M
Ambartsumian, N
Christensen, A
Selivanova, G
Lukanidin, E
机构
[1] Danish Canc Soc, Inst Canc Biol, Dept Mol Canc Biol, DK-2100 Copenhagen 0, Denmark
[2] Karolinska Inst, Ctr Microbiol & Tumor Biol, SE-17177 Stockholm, Sweden
关键词
D O I
10.1074/jbc.M010231200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A physical and functional interaction between the Ca2+-binding protein Mts1 (S100A4) and the tumor suppressor p53 protein is shown here for the first time. We demonstrate that Mts1 binds to the extreme end of the C-terminal regulatory domain of p53 by several in vitro and in vivo approaches: co-immunoprecipitation, affinity chromatography, and far Western blot analysis. The Mts1 protein in vitro inhibits phosphorylation of the full-length p53 and its C-terminal peptide by protein kinase C but not by casein kinase II. The Mts1 binding to p53 interferes with the DNA binding activity of p53 in vitro and reporter gene transactivation in, vivo, and this has a regulatory function. A differential modulation of the p53 target gene (p21/WAF: box, thrombospondin-l, and mdm-2) transcription was observed upon Mts1 induction in tet-inducible cell lines expressing wild type p53. Mts1 cooperates with wild type p53 in apoptosis induction. Our data imply that the ability of Mts1 to enhance p53 dependent apoptosis might accelerate the loss of wild type p53 function in tumors, In this way, Mts1 can contribute to the development of a more aggressive phenotype during tumor progression.
引用
收藏
页码:22699 / 22708
页数:10
相关论文
共 54 条
  • [21] Kimura M, 1997, ANTICANCER RES, V17, P879
  • [22] p53: Puzzle and paradigm
    Ko, LJ
    Prives, C
    [J]. GENES & DEVELOPMENT, 1996, 10 (09) : 1054 - 1072
  • [23] DIRECT SEQUENCING FROM TOUCH PREPARATIONS OF HUMAN CARCINOMAS - ANALYSIS OF P53 MUTATIONS IN BREAST CARCINOMAS
    KOVACH, JS
    MCGOVERN, RM
    CASSADY, JD
    SWANSON, SK
    WOLD, LE
    VOGELSTEIN, B
    SOMMER, SS
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (14): : 1004 - 1009
  • [24] Metastasis-associated Mts1 (S100A4) protein modulates protein kinase C phosphorylation of the heavy chain of nonmuscle myosin
    Kriajevska, M
    Tarabykina, S
    Bronstein, I
    Maitland, N
    Lomonosov, M
    Hansen, K
    Georgiev, G
    Lukanidin, E
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (16) : 9852 - 9856
  • [25] KRIAJEVSKA MV, 1994, J BIOL CHEM, V269, P19679
  • [26] Fra-1 induces morphological transformation and increases in vitro invasiveness and motility of epithelioid adenocarcinoma cells
    Kustikova, O
    Kramerov, D
    Grigorian, M
    Berezin, V
    Bock, E
    Lukanidin, E
    Tulchinsky, E
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (12) : 7095 - 7105
  • [27] 'Gain of function' phenotype of tumor-derived mutant p53 requires the oligomerization/nonsequence-specific nucleic acid-binding domain
    Lányi, A
    Deb, D
    Seymour, RC
    Ludes-Meyers, JH
    Subler, MA
    Deb, S
    [J]. ONCOGENE, 1998, 16 (24) : 3169 - 3176
  • [28] p53, the cellular gatekeeper for growth and division
    Levine, AJ
    [J]. CELL, 1997, 88 (03) : 323 - 331
  • [29] Lukanidin EM, 1996, CURR TOP MICROBIOL, V213, P171
  • [30] Protein interactions at the carboxyl terminus of p53 result in the induction of its in vitro transactivation potential
    Mundt, M
    Hupp, T
    Fritsche, M
    Merkle, C
    Hansen, S
    Lane, D
    Groner, B
    [J]. ONCOGENE, 1997, 15 (02) : 237 - 244